The Scientist

» clinical trials, ecology and microbiology

Most Recent

image: Microbial Smog

Microbial Smog

By | February 3, 2014

Some 1,300 species of microbes, including some associated with allergies and lung disease, are adrift in Beijing’s thick smog.

4 Comments

image: Unauthorized HIV Trial Leader Fined

Unauthorized HIV Trial Leader Fined

By | February 3, 2014

A Spanish researcher faces a penalty after conducting a study for which he never obtained proper approvals or insurance.

0 Comments

image: Self-Improvement Through the Ages

Self-Improvement Through the Ages

By | February 1, 2014

A 50,000-generation-long experiment shows that bacteria keep getting fitter.

2 Comments

image: Tenacious Termites

Tenacious Termites

By | February 1, 2014

Formosan subterranean termites evade deadly pathogens by building nests lined with their own feces.

0 Comments

image: The Necrobiome

The Necrobiome

By | February 1, 2014

Next-generation sequencing of the bacterial assemblages that inhabit a corpse throughout decomposition improve time-of-death estimates.

0 Comments

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: Bacteria by Design

Bacteria by Design

By | January 30, 2014

A survey of bacteria in a University of Oregon building reveals that architecture influences the indoor microbiome.

0 Comments

image: Stem Cell Trials in Peril?

Stem Cell Trials in Peril?

By | January 27, 2014

The only US firm with an ongoing embryonic stem cell therapy clinical trial is in financial and legal hot water.

2 Comments

image: Week in Review: January 20–24

Week in Review: January 20–24

By | January 24, 2014

Mistimed sleep disrupts human transcriptome; canine tumor genome; de novo Drosophila genes; UVA light lowers blood pressure; aquatic microfauna fight frog-killing fungus

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham